Center for Duchenne Muscular Dystrophy (CDMD) at UCLA

Duchenne Muscular Dystrophy is one of the most common and devastating genetic diseases of childhood, affecting approximately 1 in 5000 boys. Progressive muscle degeneration leads to loss of ambulation by age 12, loss of upper arm use in the teen years, and heart and respiratory failure leading to death in the 20's. The Center for Duchenne Muscular Dystrophy at UCLA leads the nation in translational science focused on Duchenne and is the first comprehensive Duchenne clinic in the western United states. A leading group of UCLA scientists, clinicians and researchers is poised to achieve significant advances in research, clinical care and treatments for Duchenne that are improving, and will potentially extend, the lives of those afflicted.

Established in 2006, the CDMD at UCLA was built as a result of collaborations among UCLA scientists, clinicians, and researchers who are now poised to achieve significant advances in research, clinical care, and treatments for Duchenne that are improving, and will potentially extend, the lives of those afflicted. The center’s efforts span from education and outreach to cutting- edge research, drug discovery, clinical trials, and care. Funding for the CDMD's remarkable achievements to date has come from a combination of research grants and private philanthropy. The goals of the CDMD are to identify additional disease modifying drug targets; perform intelligent drug design; improve access and care in the clinical setting; and increase clinical trial participation.

For more information, please visit the CDMD website.

Last updated
November 20, 2023